ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Smith & Wesson (NASDAQ:SWBI) Misses Q4 Sales Targets, Stock Drops

SWBI Cover Image

American firearms manufacturer Smith & Wesson (NASDAQ: SWBI) fell short of the market’s revenue expectations in Q4 CY2024, with sales falling 15.7% year on year to $115.9 million. Its non-GAAP profit of $0.02 per share was in line with analysts’ consensus estimates.

Is now the time to buy Smith & Wesson? Find out by accessing our full research report, it’s free.

Smith & Wesson (SWBI) Q4 CY2024 Highlights:

  • Revenue: $115.9 million vs analyst estimates of $119.5 million (15.7% year-on-year decline, 3% miss)
  • Adjusted EPS: $0.02 vs analyst estimates of $0.02 (in line)
  • Adjusted EBITDA: $13.28 million vs analyst estimates of $12.21 million (11.5% margin, 8.7% beat)
  • Operating Margin: 3.6%, down from 9% in the same quarter last year
  • Free Cash Flow was -$16.15 million, down from $7.16 million in the same quarter last year
  • Market Capitalization: $475.2 million

Company Overview

With a history dating back to 1852, Smith & Wesson (NASDAQ: SWBI) is a firearms manufacturer known for its handguns and rifles.

Leisure Products

Leisure products cover a wide range of goods in the consumer discretionary sector. Maintaining a strong brand is key to success, and those who differentiate themselves will enjoy customer loyalty and pricing power while those who don’t may find themselves in precarious positions due to the non-essential nature of their offerings.

Sales Growth

A company’s long-term sales performance can indicate its overall quality. Even a bad business can shine for one or two quarters, but a top-tier one grows for years. Unfortunately, Smith & Wesson struggled to consistently increase demand as its $493 million of sales for the trailing 12 months was close to its revenue five years ago. This was below our standards and is a sign of poor business quality.

Smith & Wesson Quarterly Revenue

We at StockStory place the most emphasis on long-term growth, but within consumer discretionary, a stretched historical view may miss a company riding a successful new product or trend. Smith & Wesson’s recent history shows its demand remained suppressed as its revenue has declined by 2.2% annually over the last two years. Smith & Wesson Year-On-Year Revenue Growth

This quarter, Smith & Wesson missed Wall Street’s estimates and reported a rather uninspiring 15.7% year-on-year revenue decline, generating $115.9 million of revenue.

Looking ahead, sell-side analysts expect revenue to grow 2.7% over the next 12 months. Although this projection implies its newer products and services will spur better top-line performance, it is still below the sector average.

Software is eating the world and there is virtually no industry left that has been untouched by it. That drives increasing demand for tools helping software developers do their jobs, whether it be monitoring critical cloud infrastructure, integrating audio and video functionality, or ensuring smooth content streaming. Click here to access a free report on our 3 favorite stocks to play this generational megatrend.

Operating Margin

Smith & Wesson’s operating margin has been trending down over the last 12 months and averaged 8.3% over the last two years. The company’s profitability was mediocre for a consumer discretionary business and shows it couldn’t pass its higher operating expenses onto its customers.

Smith & Wesson Trailing 12-Month Operating Margin (GAAP)

This quarter, Smith & Wesson generated an operating profit margin of 3.6%, down 5.4 percentage points year on year. This contraction shows it was recently less efficient because its expenses increased relative to its revenue.

Earnings Per Share

We track the long-term change in earnings per share (EPS) for the same reason as long-term revenue growth. Compared to revenue, however, EPS highlights whether a company’s growth is profitable.

Smith & Wesson’s EPS grew at a weak 1.9% compounded annual growth rate over the last five years. This performance was better than its flat revenue but doesn’t tell us much about its business quality because its operating margin didn’t expand.

Smith & Wesson Trailing 12-Month EPS (Non-GAAP)

In Q4, Smith & Wesson reported EPS at $0.02, down from $0.19 in the same quarter last year. This print was close to analysts’ estimates. Over the next 12 months, Wall Street expects Smith & Wesson’s full-year EPS of $0.56 to stay about the same.

Key Takeaways from Smith & Wesson’s Q4 Results

It was encouraging to see Smith & Wesson beat analysts’ EBITDA expectations this quarter. On the other hand, its revenue missed. Overall, this was a weaker quarter. The stock traded down 8.1% to $10.15 immediately following the results.

Smith & Wesson didn’t show it’s best hand this quarter, but does that create an opportunity to buy the stock right now? If you’re making that decision, you should consider the bigger picture of valuation, business qualities, as well as the latest earnings. We cover that in our actionable full research report which you can read here, it’s free.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.